A Study of Peginterferon Alfa-2a Plus Ribavirin in Early Non-Responder Participants With Chronic Hepatitis C (CHC) Genotype 1, 4, 5, and 6

Condition:   Hepatitis C, ChronicInterventions:   Drug: Ribavirin;   Drug: peginterferon alfa-2aSponsor:   Hoffmann-La RocheCompleted - verified June 2016

Source: ClinicalTrials.gov - May 31, 2016 Category: Research Source Type: clinical trials